The concept of tumour growth measurement by studying serial X-ray films is well established (Charbit et al., 1971) . The study of pulmonary neoplasms, mostly metastatic lesions but also primary tumours, accounts for most of this work since clearly defined "coin" lesions in the lung fields on a chest X-ray film lend themselves to direct measurement more so than tumours in any other site in the body (Chahinian & Israel, 1976 (Quastler & Sherman, 1959) . Labelled cells can be detected in histological sections by autoradiography (see Cleaver, 1967) (1967, 1968) has shown that TLI can be used to estimate the time for doubling of a tumour cell population. The al., 1973). The method devised by Steel for determining DTpot from the TLI of a tumour cell population takes account of growth fraction. It is therefore held that "cell loss", by whichever means, is the reason for the difference between the rate at which a tumour cell population doubles its volume and the rate at which the tumour cell mass actually doubles (Steel, 1967; Steel & Lamerton, 1969) . Steel coined the term "Cell Loss Factor" (0) for expressing this difference (see Materials and methods).
Cell loss factor for human tumours has, due to lack of parallel data, been estimated using results pooled from various sources in the literature (Terz et al., 1971; Malaise et al., 1973; see Steel, 1977) . In this paper we present a series of twenty seven human pulmonary neoplasms for which DT has been determined. In seventeen of these cases parallel data on DT and DTpot have been obtained and cell loss factors deduced.
Materials and methods
We have already reported a series of 58 human pulmonary neoplasms on which TLIs were determined using an in vitro technique (Kerr et al., 1983) . All 57 patients (one patient had two metastases resected) had carcinomata removed at thoracotomy in the Thoracic Surgical Unit, City Hospital, Edinburgh. In 17 of these cases serial chest X-ray films were obtainable with "measurable" (vide infra) shadows.
Ten measurable tumours, without kinetic data, were obtained from 46 other patients.
() The Macmillan Press Ltd., 1984 Histological classification of lung tumours The tumours were classified histologically on the material taken from the resected specimen for diagnostic purposes according to a modification of the WHO classification of lung tumours previously used by us (Kerr et al., 1983) .
Of the 17 cases with parallel data and 9 estimation 14 were primary bronchogenic carcinomata and 3 were metastatic lesions. The former group consisted of 5 squamous carcinomata, 3 large cell undifferentiated carcinomata (2 with and one without stratification), 3 (Kerr et al., 1983 (Kerr et al., 1983) .
Calculating actual doubling time This was done using a graphical method developed by Collins et al. (1956) .
Calculating potential doubling time DTpot can be calculated by using the relationship DTpot = ATS/TLI where A = 0.75 and Ts = 15 h (after Steel, 1967 Steel, , 1968 . Alternative values of T. from the literature derived for specific cell types of pulmonary neoplasm were also used as indicated (Table II) .
Calculating cell loss factor (0)
Steel described this as equal to 1-DTpot/DT and thus cell loss is described in terms of the proportion of cells produced by mitosis which are lost from the tumour cell population. The results of DT for differing histological tumour types from both series are shown in Figure  1 . Table I shows the data from this study compared with amalgamated results from the literature on the four major histological groups of bronchogenic carcinoma (Schwartz, 1961; Garland et al., 1963; Spratt et al., 1963; Spratt & Spratt, 1964; Weiss et al., 1966; Chahinian, 1972; Israel et al., 1973; Meyer, 1973; Steele & Buell, 1973 Adenocarcinoma, T.= 9.2 h (Rabes et al., 1979) .
All the primary lung tumours show cell loss factors of >0.7 (>70% of cells produced by mitoses are lost). Furthermore, considering the four categories of the common primary bronchogenic carcinomata, 9/14 (64%) have a cell loss of .90%. All six of the "undifferentiated" carcinomata have cell losses of >90%; those in the "large cell" category losing 93% or more of cells produced by mitosis. Conversely, there is an impression that cell loss is less in the more differentiated adenocarcinomata of various types (primary, primary "clear cell" and metastatic renal "clear cell" adenocarcinoma). However, all the groups are small and it is pertinent to comment that the largest group (4 cases of poorly differentiated squamous carcinoma) also shows the widest range of cell loss of all our histopathological groups of primary lung tumour (Figure 2 ). There is no apparent direct relationship between actual doubling time of the tumour and TLI of the tumour cell population (Table II) .
The relationship between cell loss and thymidine labelling index is shown in Figure 3 . This graph suggests that, as the TLI of a tumour cell population increases the degree of cell loss from that tumour also increases. Thus, there appears to be a tendency for tumours with TLI> 17% to have cell loss factors of 90% or more whereas tumours with TLI <5% have cell losses of <90%.
-
Discussion
Obtaining actual doubling time Between 8 and 31% of primary bronchogenic carcinomata may be "measurable" for the purposes of determining growth i,rate (Chahinian & Israel, 1976 (Steel, 1967 (Steel, , 1968 . Published data for the length of the S-phase (TJ) in human tumours suggests that assuming T, to be 15 h is reasonably justified for the cases in this study (Frindel et al., 1968; Terz et al., 1971; Muggia et al., 1974; Straus & Moran, 1977; Rabes et al., 1979) . Comparative calculations of DTpot shown in (Kerr et al., 1983) . In any case the errors estimating DTpot in this way are not even of the appropriate order of magnitude to account for the large differences (often a factor of between 10 and 100) between DTpot and DT.
Actual doubling time of lung tumours It is clear from the literature (see Table I (Weiss et al., 1966; Meyer, 1973; Steele & Buell, 1973) . This is a group of tumours with a wide range of growth rates and an unusual structure which does not fit the usual model of a solid neoplasm. Using pooled data on a heterogeneous series of human tumours Steel (1972) showed that cell loss factor 0 again increased as DT increased and conversely that tumours generally with DT < 100 days showed a lower 0 value than those with DT> 100 days. This group of human tumours, however, contained both carcinomata and sarcomata and if one considers the carcinomata alone the change in 0 with change in DT is less apparent. From our data comparing those tumours with DT > 80 days with those of DT < 80 days there is NO statistical difference between the groups.
In experimental animal tumours parallel studies have been performed (Frindel et al., 1967 ) and a trend of increasing cell loss factor with increasing DT seems apparent (Steel, 1968) .
A few other individual human tumours of various site and type have cell loss values reported in the literature (Frindel et al., 1968; Shirakawa et al., 1970; Terz et al., 1971) . These tumours had detailed cell kinetic analysis made on them but DT was not concurrently measured. Malaise et al. (1973) As mean cell loss increases from groups of tumours of one histological type to another then so does the mean TLI of the group. Thus as growth fraction increases cell loss does also (Malaise et al., 1973; Tubiana & Malaise, 1975) . Our data confirm the relation between cell loss increase and both increasing % TLI and loss of tumour differentiation. Why does this relationship exist? Is it that cell replication carries with it a certain "casualty rate" or that increased expansion rate in a cell population means too great a demand on nutrient supply leading to cell death (Malaise et al., 1973) ? Of relevance in this context is the finding that increased cell loss makes tumour response to chemotherapy more likely (Bagshawe, 1968) ; this being especially so, as we might expect, in tumours with a high TLI (Tubiana & Malaise, 1975 (Kerr et al., 1983) to other groups'. Thus mean 0 in small cell cancer as a group may be less than in other types of bronchogenic carcinoma. Adequate data are sparse but it is possible that more detailed investigation may reveal subpopulations of small cell carcinoma with "kinetic" differences.
This parallel study of actual growth and simple cell kinetic parameters has shown that cell loss from the tumour cell population is an important determinant of actual growth rate in human pulmonary neoplasms. Other important determinants are growth fraction and cell cycle time. In human tumours ALL these factors, however, are difficult to measure. While we are very aware of the errors involved with, and the criticisms that have been levelled against the measurements, assumptions and calculations we have been concerned with in this study (Garland et al., 1963; Gurland & Johnson, 1965 Steel, 1968; Steel and Lamerton, 1969) data such as these may help towards a better understanding of the behaviour of human bronchogenic carcinoma.
